Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Semaphorin 7a ELISA Kit (AC2995)
Cat.#: ASET-1584
Specifications
Description Human Semaphorin 7a ELISA Kit allows for the in vitro quantitative determination of human Semaphorin 7a concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1860 Human NR1D1 ELISA Kit (AC3271) Quantitative inquiry ASET-1948 Mouse IRS1 ELISA Kit (AC3359) Quantitative inquiry ASET-1771 Rat Neuroglobin ELISA Kit (AC3182) Quantitative inquiry ASET-1028 Mouse FGF1 ELISA Kit (AC2439) Quantitative inquiry ASET-2326 Mouse SFRP1 ELISA Kit (AC3737) Quantitative inquiry ASET-1625 Human TDP43 ELISA Kit (AC3036) Quantitative inquiry ASET-1224 Human HIP1 ELISA Kit (AC2635) Quantitative inquiry ASET-2510 Mouse beta 1 Adrenergic Receptor ELISA Kit (AC3921) Quantitative inquiry ASET-2331 Mouse 14-3-3 zeta ELISA Kit (AC3742) Quantitative inquiry ASET-1760 Human GLP-1R ELISA Kit (AC3171) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket